eLife (Apr 2024)
Context-dependent modification of PFKFB3 in hematopoietic stem cells promotes anaerobic glycolysis and ensures stress hematopoiesis
- Shintaro Watanuki,
- Hiroshi Kobayashi,
- Yuki Sugiura,
- Masamichi Yamamoto,
- Daiki Karigane,
- Kohei Shiroshita,
- Yuriko Sorimachi,
- Shinya Fujita,
- Takayuki Morikawa,
- Shuhei Koide,
- Motohiko Oshima,
- Akira Nishiyama,
- Koichi Murakami,
- Miho Haraguchi,
- Shinpei Tamaki,
- Takehiro Yamamoto,
- Tomohiro Yabushita,
- Yosuke Tanaka,
- Go Nagamatsu,
- Hiroaki Honda,
- Shinichiro Okamoto,
- Nobuhito Goda,
- Tomohiko Tamura,
- Ayako Nakamura-Ishizu,
- Makoto Suematsu,
- Atsushi Iwama,
- Toshio Suda,
- Keiyo Takubo
Affiliations
- Shintaro Watanuki
- ORCiD
- Department of Stem Cell Biology, Research Institute, National Center for Global Health and Medicine, Tokyo, Japan; Division of Hematology, Department of Medicine, Keio University School of Medicine, Tokyo, Japan
- Hiroshi Kobayashi
- ORCiD
- Department of Stem Cell Biology, Research Institute, National Center for Global Health and Medicine, Tokyo, Japan; Department of Cell Fate Biology and Stem Cell Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan
- Yuki Sugiura
- ORCiD
- Department of Biochemistry, Keio University School of Medicine, Tokyo, Japan; Center for Cancer Immunotherapy and Immunobiology, Kyoto University Graduate School of Medicine, Kyoto, Japan
- Masamichi Yamamoto
- Department of Research Promotion and Management, National Cerebral and Cardiovascular Center, Osaka, Japan
- Daiki Karigane
- ORCiD
- Department of Stem Cell Biology, Research Institute, National Center for Global Health and Medicine, Tokyo, Japan; Division of Hematology, Department of Medicine, Keio University School of Medicine, Tokyo, Japan
- Kohei Shiroshita
- Department of Stem Cell Biology, Research Institute, National Center for Global Health and Medicine, Tokyo, Japan; Division of Hematology, Department of Medicine, Keio University School of Medicine, Tokyo, Japan
- Yuriko Sorimachi
- Department of Stem Cell Biology, Research Institute, National Center for Global Health and Medicine, Tokyo, Japan; Department of Life Sciences and Medical BioScience, Waseda University School of Advanced Science and Engineering, Tokyo, Japan
- Shinya Fujita
- Department of Stem Cell Biology, Research Institute, National Center for Global Health and Medicine, Tokyo, Japan; Division of Hematology, Department of Medicine, Keio University School of Medicine, Tokyo, Japan
- Takayuki Morikawa
- Department of Stem Cell Biology, Research Institute, National Center for Global Health and Medicine, Tokyo, Japan
- Shuhei Koide
- Division of Stem Cell and Molecular Medicine, Center for Stem Cell Biology and Regenerative Medicine, The Institute of Medical Science, University of Tokyo, Tokyo, Japan
- Motohiko Oshima
- Division of Stem Cell and Molecular Medicine, Center for Stem Cell Biology and Regenerative Medicine, The Institute of Medical Science, University of Tokyo, Tokyo, Japan
- Akira Nishiyama
- Department of Immunology, Yokohama City University Graduate School of Medicine, Kanagawa, Japan
- Koichi Murakami
- Department of Immunology, Yokohama City University Graduate School of Medicine, Kanagawa, Japan; Advanced Medical Research Center, Yokohama City University, Kanagawa, Japan
- Miho Haraguchi
- Department of Stem Cell Biology, Research Institute, National Center for Global Health and Medicine, Tokyo, Japan
- Shinpei Tamaki
- Department of Stem Cell Biology, Research Institute, National Center for Global Health and Medicine, Tokyo, Japan
- Takehiro Yamamoto
- ORCiD
- Department of Biochemistry, Keio University School of Medicine, Tokyo, Japan
- Tomohiro Yabushita
- Division of Cellular Therapy, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan
- Yosuke Tanaka
- International Research Center for Medical Sciences, Kumamoto University, Kumamoto, Japan
- Go Nagamatsu
- Center for Advanced Assisted Reproductive Technologies, University of Yamanashi, Yamanashi, Japan; Precursory Research for Embryonic Science and Technology, Japan Science and Technology Agency, Saitama, Japan
- Hiroaki Honda
- Field of Human Disease Models, Major in Advanced Life Sciences and Medicine, Institute of Laboratory Animals, Tokyo Women's Medical University, Tokyo, Japan
- Shinichiro Okamoto
- Division of Hematology, Department of Medicine, Keio University School of Medicine, Tokyo, Japan
- Nobuhito Goda
- Department of Life Sciences and Medical BioScience, Waseda University School of Advanced Science and Engineering, Tokyo, Japan
- Tomohiko Tamura
- Department of Immunology, Yokohama City University Graduate School of Medicine, Kanagawa, Japan; Advanced Medical Research Center, Yokohama City University, Kanagawa, Japan
- Ayako Nakamura-Ishizu
- Department of Microscopic and Developmental Anatomy, Tokyo Women's Medical University, Tokyo, Japan
- Makoto Suematsu
- Department of Biochemistry, Keio University School of Medicine, Tokyo, Japan; Live Imaging Center, Central Institute for Experimental Animals, Kanagawa, Japan
- Atsushi Iwama
- ORCiD
- Division of Stem Cell and Molecular Medicine, Center for Stem Cell Biology and Regenerative Medicine, The Institute of Medical Science, University of Tokyo, Tokyo, Japan
- Toshio Suda
- International Research Center for Medical Sciences, Kumamoto University, Kumamoto, Japan; Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore
- Keiyo Takubo
- ORCiD
- Department of Stem Cell Biology, Research Institute, National Center for Global Health and Medicine, Tokyo, Japan; Department of Cell Fate Biology and Stem Cell Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan
- DOI
- https://doi.org/10.7554/eLife.87674
- Journal volume & issue
-
Vol. 12
Abstract
Metabolic pathways are plastic and rapidly change in response to stress or perturbation. Current metabolic profiling techniques require lysis of many cells, complicating the tracking of metabolic changes over time after stress in rare cells such as hematopoietic stem cells (HSCs). Here, we aimed to identify the key metabolic enzymes that define differences in glycolytic metabolism between steady-state and stress conditions in murine HSCs and elucidate their regulatory mechanisms. Through quantitative 13C metabolic flux analysis of glucose metabolism using high-sensitivity glucose tracing and mathematical modeling, we found that HSCs activate the glycolytic rate-limiting enzyme phosphofructokinase (PFK) during proliferation and oxidative phosphorylation (OXPHOS) inhibition. Real-time measurement of ATP levels in single HSCs demonstrated that proliferative stress or OXPHOS inhibition led to accelerated glycolysis via increased activity of PFKFB3, the enzyme regulating an allosteric PFK activator, within seconds to meet ATP requirements. Furthermore, varying stresses differentially activated PFKFB3 via PRMT1-dependent methylation during proliferative stress and via AMPK-dependent phosphorylation during OXPHOS inhibition. Overexpression of Pfkfb3 induced HSC proliferation and promoted differentiated cell production, whereas inhibition or loss of Pfkfb3 suppressed them. This study reveals the flexible and multilayered regulation of HSC glycolytic metabolism to sustain hematopoiesis under stress and provides techniques to better understand the physiological metabolism of rare hematopoietic cells.
Keywords
- hematopoietic stem cell
- stem cell metabolism
- stress hematopoiesis
- single-cell atp analysis
- metabolomics
- PFKFB3